SCHEMBL26697244

SCHEMBL26697244

COc1cc2c(Oc3ccc(NC(=O)Nc4ccncc4)c(Cl)c3)ncnc2cc1OCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.72
FLT1 P17948 12/20 0.72
FLT4 P35916 12/20 0.72
KIT P10721 1/20 0.64
PDGFRA P16234 1/20 0.64
CSF1R P07333 1/20 0.63
BRAF P15056 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26697235 0.95 KDR (0.73) KDRFLT1FLT4KITPDGFRA
SCHEMBL26894914 0.92 KDR (0.76) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697250 0.92 KDR (0.72) KDRFLT1FLT4KITPDGFRA
SCHEMBL26894823 0.92 KDR (0.67) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697248 0.91 KDR (0.73) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697264 0.90 KDR (0.71) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697210 0.89 KDR (0.73) KDRFLT1FLT4KITPDGFRA
SCHEMBL29757938 0.88 KDR (0.65) KDRFLT1FLT4KITPDGFRA
SCHEMBL26894877 0.88 KDR (0.65) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697306 0.87 KDR (0.77) KDRFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114920703-B Quinazoline derivative and preparation method and application thereof 天津济坤医药科技有限公司 2024-01-09 CN disclosed
WO-2023226323-A1 QUINAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 天津济坤医药科技有限公司 2023-11-30 WO disclosed
WO-2023226323-A1 QUINAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 天津济坤医药科技有限公司 2023-11-30 WO disclosed
CN-114920703-A Quinazoline derivative and preparation method and application thereof 天津济坤医药科技有限公司 2022-08-19 CN disclosed